microarrays
Through a US-based subsidiary, the South Korean firm has received breakthrough device designation for its bladder cancer test that could accelerate it to market.
Deciphering Developmental Disorders Study Provides Molecular Diagnosis to 41 Percent of Patients
Members of the DDD study team diagnosed more than 5,500 children with rare diseases from the UK and Ireland using exome sequencing and microarrays.
End-Stage Ovarian Cancer Marked by Rampant Treatment Resistance, Multiple Clones
By profiling multiple tumors per patient, researchers found pronounced polyclonal disease and diverse resistance mechanisms in end-stage high-grade serous ovarian carcinoma.
South Carolina Population Genomics Program Marks First Anniversary With Surge in Participation
Premium
The In Our DNA SC partnership between MUSC and Helix is still struggling to match the diversity of the South Carolina population, but outreach is expanding.
Asa Ren, G42 Healthcare Partner to Promote Genomics, Bioinformatics in Indonesia
Signed on the sidelines of the G20 summit, the partnership aims to support Indonesia's Biomedical and Genome Science Initiative for precision medicine.